Volume 15, Number 3—March 2009
Merkel Cell Polyomavirus DNA in Respiratory Specimens from Children and Adults
|Age||Sex||Immune status||Clinical history||Signs and symptoms|
|MCV-B1 (LT3: FJ009185, VP1: FJ009188)||29.0||–||52.0 y||M||Suppressed||Acute myeloid leukemia||Flu-like|
|MCV-B2 (LT3: FJ009186, VP1: FJ009189)||33.0||–||6.6 y||F||Suppressed||Heart transplant, T-cell lymphoma||Coryza, fever, sore throat, ear pain|
|MCV-B3 (LT3: FJ009187, VP1: FJ009190)||31.5||–||47.7 y||M||Suppressed||Heart transplant||–|
|MCV-B4||36.9||–||8 mo, 8 d||M||Competent||–||Bronchiolitis|
|MCV-B5||37.5||–||1 mo, 26 d||M||Competent||–||Rhinorrhea, cough|
|MCV-B6||37.4||–||9 mo, 27 d||F||Competent||–|
|MCV-B7||38.9||Adenovirus, WUPyV||1.6 y||F||Competent||–||Fever, convulsions|
*MCPyV, Merkel cell polyomavirus; Ct, cycle threshold; WUPyV, WU polyomavirus.
†Clinical histories and symptoms were noted when available. Associated GenBank accession numbers are shown in parentheses.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.